http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-577546-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebec4b6958973a1f4c3b880b5f11658c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D339-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C281-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C281-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D339-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2007-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_126997a32c63e2de13001da06e670b51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_405a9e88c5f2ac5bc260171c298a0c62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8c3eeb396ca7a7b3969e6858c19d668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e264427b0bafec7fdd7e1fb1d64898e
publicationDate 2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-577546-A
titleOfInvention Aminoguanidines as melanocortin receptor ligands useful for the treatment of inflammation and autoimmunie disorders
abstract Disclosed are aminoguanidine compounds of formula (I), salts thereof, and methods for their preparation. Specific examples of compounds of formula (I) include: N-(2-Methylthio-3-chlorobenzylideneamino)guanidine hydrochloride, N-(2-Chloro-(3-ethoxycarbonyl)-benzylideneamino)guanidine trifiouroacetate, N-(2-Chloro-3,4-dimethylthiobenzylideneamino)guanidine, N-(2-MethyIthio-3-chlorophenylpropylideneamino)guanidine, N-(2-Chloro-4-Methoxy-3-methylthiophenylpropylideneamino)guanidine, and N-(2-Chloro-3-Methoxy-4-methylthiophenylpropylideneamino)guanidine. Compounds of formula (I) are useful for treating inflammation such as arthritic conditions and for inducing central nerve regeneration.
priorityDate 2006-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412881941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447495970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68791433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152403206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419070288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68792836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417744184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151285426

Total number of triples: 39.